The Wall Street Journal @WSJ
Moderna said its tweaked Covid-19 vaccine, which targets both the original virus strain and Omicron, produced a strong immune response against subvariants BA.4 and BA.5 in a study https://t.co/uqm3txp7dz — PolitiTweet.org